1. From the Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, University of California, San Francisco Comprehensive Cancer Center, University of California, San Francisco (CJK, WWB, NS, DJP, MRC, JMC, PRC), Veterans Affairs Medical Center (CJK), San Francisco, California, and TAP Pharmaceutical Products, Inc. (SS, KW), Lake Forest, Illinois